# Fidelity National Information Services, Inc.: financial statements, quarterly

FIS · NYSE · CIK 1136893 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fis.md) · [Financials](/companies/fis/financials.md) · [Filings](/companies/fis/filings.md) · [Insiders](/companies/fis/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fis/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,492](/filings/0001136893-25-000014.md) | [2,512](/filings/0001136893-25-000014.md) | [2,468](/filings/0001136893-26-000013.md) | [2,490](/filings/0001136893-26-000013.md) | [2,570](/filings/0001136893-26-000013.md) | [2,599](/filings/0001136893-26-000013.md) | [2,532](/filings/0001136893-26-000040.md) | [2,616](/filings/0001136893-26-000050.md) | [2,717](/filings/0001136893-26-000013.md) | [2,812](/filings/0001136893-26-000013.md) | [3,295](/filings/0001136893-26-000040.md) | [3,377](/filings/0001136893-26-000050.md) |
| Cost of revenue | $m | [1,531](/filings/0001136893-24-000139.md) | [1,542](/filings/0001136893-24-000139.md) | [1,559](/filings/0001136893-25-000056.md) | [1,546](/filings/0001136893-25-000117.md) | [1,593](/filings/0001136893-25-000128.md) | [1,623 d](/filings/0001136893-26-000013.md) | [1,653](/filings/0001136893-26-000040.md) | [1,664](/filings/0001136893-26-000050.md) | [1,689](/filings/0001136893-25-000128.md) | [1,735 d](/filings/0001136893-26-000013.md) | [2,187](/filings/0001136893-26-000040.md) | [2,203](/filings/0001136893-26-000050.md) |
| Gross profit | $m | [961](/filings/0001136893-25-000014.md) | [970](/filings/0001136893-25-000014.md) | [909](/filings/0001136893-26-000013.md) | [944](/filings/0001136893-26-000013.md) | [977](/filings/0001136893-26-000013.md) | [977](/filings/0001136893-26-000013.md) | [879](/filings/0001136893-26-000040.md) | [952](/filings/0001136893-26-000050.md) | [1,028](/filings/0001136893-26-000013.md) | [1,076](/filings/0001136893-26-000013.md) | [1,108](/filings/0001136893-26-000040.md) | [1,174](/filings/0001136893-26-000050.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [484](/filings/0001136893-24-000139.md) | [539 d](/filings/0001136893-26-000013.md) | [573](/filings/0001136893-25-000056.md) | [609](/filings/0001136893-25-000117.md) | [521](/filings/0001136893-25-000128.md) | [482 d](/filings/0001136893-26-000013.md) | [558](/filings/0001136893-26-000040.md) | [572](/filings/0001136893-26-000050.md) | [584](/filings/0001136893-25-000128.md) | [550 d](/filings/0001136893-26-000013.md) | [605](/filings/0001136893-26-000040.md) | [684](/filings/0001136893-26-000050.md) |
| Operating income | $m | [470](/filings/0001136893-25-000014.md) | [326](/filings/0001136893-25-000014.md) | [354](/filings/0001136893-26-000013.md) | [371](/filings/0001136893-26-000013.md) | [490](/filings/0001136893-26-000013.md) | [494](/filings/0001136893-26-000013.md) | [347](/filings/0001136893-26-000040.md) | [408](/filings/0001136893-26-000050.md) | [457](/filings/0001136893-26-000013.md) | [529](/filings/0001136893-26-000013.md) | [423](/filings/0001136893-26-000040.md) | [507](/filings/0001136893-26-000050.md) |
| Interest expense | $m | not reported | not reported | [77.0](/filings/0001136893-25-000056.md) | [43.0](/filings/0001136893-25-000117.md) | [64.0](/filings/0001136893-25-000128.md) | [167 d](/filings/0001136893-26-000013.md) | [80.0](/filings/0001136893-26-000040.md) | [110](/filings/0001136893-26-000050.md) | [90.0](/filings/0001136893-25-000128.md) | [112 d](/filings/0001136893-26-000013.md) | [197](/filings/0001136893-26-000040.md) | [200](/filings/0001136893-26-000050.md) |
| Income tax | $m | [70.0](/filings/0001136893-24-000139.md) | [15.0](/filings/0001136893-24-000139.md) | [20.0](/filings/0001136893-25-000056.md) | [87.0](/filings/0001136893-25-000117.md) | [108](/filings/0001136893-25-000128.md) | [147 d](/filings/0001136893-26-000013.md) | [81.0](/filings/0001136893-26-000040.md) | [10.0](/filings/0001136893-26-000050.md) | [87.0](/filings/0001136893-25-000128.md) | [86.0 d](/filings/0001136893-26-000013.md) | [106](/filings/0001136893-26-000040.md) | [63.0](/filings/0001136893-26-000050.md) |
| Net income | $m | [(461)](/filings/0001136893-25-000014.md) | [248](/filings/0001136893-25-000014.md) | [706](/filings/0001136893-26-000013.md) | [238](/filings/0001136893-26-000013.md) | [224](/filings/0001136893-26-000013.md) | [281](/filings/0001136893-26-000013.md) | [77.0](/filings/0001136893-26-000040.md) | [(470)](/filings/0001136893-26-000050.md) | [264](/filings/0001136893-26-000013.md) | [511](/filings/0001136893-26-000013.md) | [2,366](/filings/0001136893-26-000040.md) | [231](/filings/0001136893-26-000050.md) |
| Diluted EPS | $ per share | [(0.78)](/filings/0001136893-24-000139.md) | [0.42](/filings/0001136893-24-000139.md) | [1.22](/filings/0001136893-25-000056.md) | [0.43](/filings/0001136893-25-000117.md) | [0.41](/filings/0001136893-25-000128.md) | not reported | [0.15](/filings/0001136893-26-000040.md) | [(0.90)](/filings/0001136893-26-000050.md) | [0.50](/filings/0001136893-25-000128.md) | not reported | [4.58](/filings/0001136893-26-000040.md) | [0.45](/filings/0001136893-26-000050.md) |
| Basic EPS | $ per share | [(0.78)](/filings/0001136893-24-000139.md) | [0.42](/filings/0001136893-24-000139.md) | [1.23](/filings/0001136893-25-000056.md) | [0.43](/filings/0001136893-25-000117.md) | [0.41](/filings/0001136893-25-000128.md) | not reported | [0.15](/filings/0001136893-26-000040.md) | [(0.90)](/filings/0001136893-26-000050.md) | [0.51](/filings/0001136893-25-000128.md) | not reported | [4.59](/filings/0001136893-26-000040.md) | [0.45](/filings/0001136893-26-000050.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001136893-23-000148.md) | [0.4](/filings/0001136893-25-000014.md) | [3.3](/filings/0001136893-24-000063.md) | [2.1](/filings/0001136893-24-000113.md) | [1.3](/filings/0001136893-24-000139.md) | [0.8](/filings/0001136893-26-000013.md) | [0.8](/filings/0001136893-25-000056.md) | [0.6](/filings/0001136893-25-000117.md) | [0.6](/filings/0001136893-25-000128.md) | [0.6](/filings/0001136893-26-000050.md) | [0.8](/filings/0001136893-26-000040.md) | [0.7](/filings/0001136893-26-000050.md) |
| Current assets | $bn | [12.2](/filings/0001136893-23-000148.md) | [13.7](/filings/0001136893-25-000014.md) | [7.6](/filings/0001136893-24-000063.md) | [6.5](/filings/0001136893-24-000113.md) | [6.1](/filings/0001136893-24-000139.md) | [5.2](/filings/0001136893-26-000013.md) | [4.4](/filings/0001136893-25-000056.md) | [4.4](/filings/0001136893-25-000117.md) | [4.0](/filings/0001136893-25-000128.md) | [4.5](/filings/0001136893-26-000050.md) | [5.0](/filings/0001136893-26-000040.md) | [5.3](/filings/0001136893-26-000050.md) |
| Total assets | $bn | [53.2](/filings/0001136893-23-000148.md) | [55.0](/filings/0001136893-25-000014.md) | [35.9](/filings/0001136893-24-000063.md) | [34.6](/filings/0001136893-24-000113.md) | [34.3](/filings/0001136893-24-000139.md) | [33.8](/filings/0001136893-26-000013.md) | [32.8](/filings/0001136893-25-000056.md) | [33.4](/filings/0001136893-25-000117.md) | [33.0](/filings/0001136893-25-000128.md) | [33.5](/filings/0001136893-26-000050.md) | [43.5](/filings/0001136893-26-000040.md) | [44.1](/filings/0001136893-26-000050.md) |
| Current liabilities | $bn | [16.1](/filings/0001136893-23-000148.md) | [18.2](/filings/0001136893-25-000014.md) | [5.0](/filings/0001136893-24-000063.md) | [4.8](/filings/0001136893-24-000113.md) | [5.1](/filings/0001136893-24-000139.md) | [6.1](/filings/0001136893-26-000013.md) | [7.0](/filings/0001136893-25-000056.md) | [7.4](/filings/0001136893-25-000117.md) | [7.5](/filings/0001136893-25-000128.md) | [7.6](/filings/0001136893-26-000050.md) | [8.5](/filings/0001136893-26-000040.md) | [9.9](/filings/0001136893-26-000050.md) |
| Total liabilities | $bn | [33.7](/filings/0001136893-23-000148.md) | [35.9](/filings/0001136893-25-000014.md) | [17.8](/filings/0001136893-24-000063.md) | [17.6](/filings/0001136893-24-000113.md) | [17.8](/filings/0001136893-24-000139.md) | [18.1](/filings/0001136893-26-000013.md) | [17.8](/filings/0001136893-25-000056.md) | [19.2](/filings/0001136893-25-000117.md) | [19.2](/filings/0001136893-25-000128.md) | [19.6](/filings/0001136893-26-000050.md) | [27.5](/filings/0001136893-26-000040.md) | [28.1](/filings/0001136893-26-000050.md) |
| Long-term debt | $bn | [12.7](/filings/0001136893-23-000148.md) | [13.0](/filings/0001136893-25-000014.md) | [10.6](/filings/0001136893-24-000063.md) | [10.6](/filings/0001136893-24-000113.md) | [10.5](/filings/0001136893-24-000139.md) | [9.7](/filings/0001136893-26-000013.md) | [8.7](/filings/0001136893-25-000056.md) | [8.9](/filings/0001136893-25-000117.md) | [8.9](/filings/0001136893-25-000128.md) | [9.1](/filings/0001136893-26-000050.md) | [16.8](/filings/0001136893-26-000040.md) | [15.4](/filings/0001136893-26-000050.md) |
| Current portion of debt | $bn | [1.3](/filings/0001136893-23-000148.md) | [1.3](/filings/0001136893-25-000014.md) | [0.6](/filings/0001136893-24-000063.md) | [0.6](/filings/0001136893-24-000113.md) | [0.3](/filings/0001136893-24-000139.md) | [1.0](/filings/0001136893-26-000013.md) | [2.3](/filings/0001136893-25-000056.md) | [2.3](/filings/0001136893-25-000117.md) | [2.0](/filings/0001136893-25-000128.md) | [1.3](/filings/0001136893-26-000050.md) | [0.1](/filings/0001136893-26-000040.md) | [1.5](/filings/0001136893-26-000050.md) |
| Short-term borrowings | $bn | [4.6](/filings/0001136893-23-000148.md) | [4.8](/filings/0001136893-25-000014.md) | [0.0](/filings/0001136893-24-000063.md) | [0.0](/filings/0001136893-24-000113.md) | [0.1](/filings/0001136893-24-000139.md) | [0.6](/filings/0001136893-26-000013.md) | [1.1](/filings/0001136893-25-000056.md) | [1.7](/filings/0001136893-25-000117.md) | [2.1](/filings/0001136893-25-000128.md) | [2.7](/filings/0001136893-26-000050.md) | [4.2](/filings/0001136893-26-000040.md) | [4.2](/filings/0001136893-26-000050.md) |
| Shareholders' equity | $bn | [19.5](/filings/0001136893-23-000148.md) | [19.1](/filings/0001136893-25-000014.md) | [18.0](/filings/0001136893-24-000063.md) | [17.0](/filings/0001136893-24-000113.md) | [16.6](/filings/0001136893-24-000139.md) | [15.7](/filings/0001136893-26-000013.md) | [15.1](/filings/0001136893-25-000056.md) | [14.2](/filings/0001136893-25-000117.md) | [13.9](/filings/0001136893-25-000128.md) | [13.9](/filings/0001136893-26-000050.md) | [16.0](/filings/0001136893-26-000040.md) | [16.0](/filings/0001136893-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,091 d](/filings/0001136893-23-000148.md) | [1,525 d](/filings/0001136893-24-000015.md) | [206](/filings/0001136893-25-000056.md) | [546 d](/filings/0001136893-25-000117.md) | [641 d](/filings/0001136893-25-000128.md) | [782 d](/filings/0001136893-26-000013.md) | [457](/filings/0001136893-26-000040.md) | [382 d](/filings/0001136893-26-000050.md) | [1,011 d](/filings/0001136893-25-000128.md) | [758 d](/filings/0001136893-26-000013.md) | [713](/filings/0001136893-26-000040.md) | [494 d](/filings/0001136893-26-000050.md) |
| Capital expenditure | $m | [215](/filings/0001136893-24-000139.md) | [27.0 d](/filings/0001136893-26-000013.md) | [27.0](/filings/0001136893-25-000056.md) | [183](/filings/0001136893-24-000113.md) | [243](/filings/0001136893-24-000139.md) | [18.0 d](/filings/0001136893-26-000013.md) | [37.0](/filings/0001136893-26-000040.md) | [39.0 d](/filings/0001136893-26-000050.md) | [59.0 d](/filings/0001136893-25-000128.md) | [19.0 d](/filings/0001136893-26-000013.md) | [50.0](/filings/0001136893-26-000040.md) | [26.0 d](/filings/0001136893-26-000050.md) |
| Dividends paid | $m | [308 d](/filings/0001136893-24-000139.md) | [305 d](/filings/0001136893-26-000013.md) | [209](/filings/0001136893-25-000056.md) | [200 d](/filings/0001136893-25-000117.md) | [199 d](/filings/0001136893-25-000128.md) | [192 d](/filings/0001136893-26-000013.md) | [220](/filings/0001136893-26-000040.md) | [212 d](/filings/0001136893-26-000050.md) | [208 d](/filings/0001136893-25-000128.md) | [207 d](/filings/0001136893-26-000013.md) | [232](/filings/0001136893-26-000040.md) | [228 d](/filings/0001136893-26-000050.md) |
| Share repurchases | $m | [1.0 d](/filings/0001136893-24-000139.md) | [506 d](/filings/0001136893-26-000013.md) | [1,342](/filings/0001136893-25-000056.md) | [1,180 d](/filings/0001136893-25-000117.md) | [510 d](/filings/0001136893-25-000128.md) | [1,013 d](/filings/0001136893-26-000013.md) | [537](/filings/0001136893-26-000040.md) | [287 d](/filings/0001136893-26-000050.md) | [308 d](/filings/0001136893-25-000128.md) | [293 d](/filings/0001136893-26-000013.md) | [67.0](/filings/0001136893-26-000040.md) | [52.0 d](/filings/0001136893-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [592](/filings/0001136893-25-000014.md) | [591](/filings/0001136893-25-000014.md) | [578](/filings/0001136893-26-000013.md) | [557](/filings/0001136893-26-000013.md) | [548](/filings/0001136893-26-000013.md) | [540](/filings/0001136893-26-000013.md) | [531](/filings/0001136893-26-000040.md) | [525](/filings/0001136893-26-000050.md) | [523](/filings/0001136893-26-000013.md) | [519](/filings/0001136893-26-000013.md) | [517](/filings/0001136893-26-000040.md) | [517](/filings/0001136893-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 515,705,917 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001136893-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.